Retinoid X receptor-specific retinoids inhibit the ability of retinoic acid receptor-specific retinoids to increase the level of insulin-like growth factor binding protein-3 in human ectocervical epithelial cells

Cancer Research

Volumn 56, Issue 8, 1996, Pages 1794-1799

  Hembree, Joan R ^a   Agarwal, Chapla ^a   Beard, Richard L ^b   Chandraratna, Roshantha A S ^b   Eckert, Richard L ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ALLERGAN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [2 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL) 1,3 DIOXOL 2 YL]BENZOIC ACID; 4 [2 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL) 1,3 DIOXOLAN 2 YL]BENZOIC ACID; 4 [2 METHYL 1 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL) 1 PROPENYL]BENZOIC ACID; 5 [2 (5,6,7,8 TETRAHYDRO 3,5,5,8,8 PENTAMETHYL 2 NAPHTHYL) 1 PROPENYL] 3 THENOIC ACID; AGN 191701; ALITRETINOIN; ISOTRETINOIN; LIGAND; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID DERIVATIVE; RETINOID X RECEPTOR; RETINOL; SOMATOMEDIN BINDING PROTEIN 3; UNCLASSIFIED DRUG;

ARTICLE; CANCER PREVENTION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; GENE TARGETING; HORMONE RECEPTOR INTERACTION; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FAMILY; UTERINE CERVIX CARCINOMA;

CELL DIVISION; CELL LINE, TRANSFORMED; CERVIX UTERI; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIUM; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; KINETICS; PAPILLOMAVIRIDAE; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; RETINOIDS; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION FACTORS;

EID: 0029921233     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Giguere, V. Retinoic acid receptors and cellular retinoid binding proteins, complex interplay in retinoid signaling Endocr Rev., 15: 61-79, 1994.
2. Gudas, L. J. Retinoids and vertebrate development J. Biol. Chem., 269: 15399-15402, 1994.
3. Giguere, V., Ong, E S., Segui, P., and Evans, R. M. Identification of a receptor for the morphogen retinoic acid. Nature (Lond.), 330: 624-629, 1987
4. Petkovich, M., Brand, N. J., Krust, A , and Chambon, P. A human retinoic acid receptor which belongs to the family of nuclear receptors Nature (Lond.), 330: 444-450, 1987.
5. Brand, N., Petkovich, M., Krust, A , Chambon, P , de The, H., Marchio, A., Tiollais, P , and Dejean, A. Identification of a second human retinoic acid receptor. Nature (Lond), 332: 850-853, 1988
6. Benbrook, D., Lernhardt, E., and Pfahl, M. A new retinoic acid receptor identified from a hepatocellular carcinoma. Nature (Lond), 333: 669-672, 1988.
7. Zelent, A., Krust, A., Petkovich, M , Kastner, P., and Chambon, P. Cloning of murine α and β retinoic acid receptors and a novel receptor gamma predominantly expressed in skin Nature (Lond.), 339: 714-717, 1989
8. Ishikawa, T., Umesono, K., Mangelsdorf, D. J , Aburatani, H , Stanger, B Z., Shibasaki, Y , Imawan, M., Evans, R. M , and Takaku, F. A functional retinoic acid receptor encoded by the gene on human chromosome 12. Mol. Endocrinol., 4: 837-844, 1990.
9. Krust, A., Kastner, P., Petkovich, M., Zelent, A , and Chambon, P. A third human retinoic acid receptor, hRAR γ. Proc. Natl. Acad. Sci. USA, 86: 5310-5314, 1989.
10. Heyman, R A , Mangelsdorf, D. J , Dyck, J. A , Stein, R B , Eichele, G., Evans, R. M., and Thaller, C 9-cis Retinoic acid is a high affinity ligand for the retinoid X receptor. Cell, 68, 397-406, 1992.
11. Mangelsdorf, D. J , Borgmeyer, U., Heyman, R A , Zhou, J. Y., Ong, E. S , Oro, A E., Kakizuka, A , and Evans, R. M. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes & Dev., 6: 329-344, 1992
12. Lippman, S M, Kavanagh, J J , Paredes-Espinoza, M., Delgadillo-Madrueno, F , Paredes-Casillas, P., Hong, W K., Massimini, G., Holdener, E. E., and Krakoff, I H 13-cis-Retinoic acid plus interferon-α 2a in locally advanced squamous cell carcinoma of the cervix J. Natl Cancer Inst , 85: 499-500, 1993
13. Agarwal, C., Hembree, J. R , Rorke, E A , and Eckert, R L. Interferon and retinoic acid suppress the growth of human papillomavirus type 16 immortalized cervical epithelial cells, but only interferon suppresses the level of the human papillomavirus transforming oncogenes. Cancer Res., 54: 2108-2112, 1994.
14. Gorodeski, G I , Eckert, R. L., Uttan, W H., Sheean, L., and Rorke, E. A Retinoids, sex steroids and glucocorticoids regulate ectocervical cell envelope formation but not the level of the envelope precursor, involucrin. Differentiation, 42, 75-80, 1989
15. Choo, C. K., Rorke, E A , and Eckert, R. L. Calcium regulates the differentiation of human papillomavirus type 16 (HPV16) immortalized ectocervical epithelial cells, but not the expression of the papillomavirus E6 and E7 oncogenes Exp. Cell Res , 208: 161-169, 1993
16. Gorodeski, G. I , Eckert R. L , Utian, W. H., and Rorke, E. A. Maintenance of in vivo-like keratin expression, sex steroid responsiveness, and estrogen receptor expression in cultured human ectocervical epithelial cells Endocrinology, 126: 399-406, 1990.
17. Kasturi, L., Sizemore, N., Eckert, R L., Martin, K., and Rorke, E. A. Calcium modulates cornified envelope formation, involucrin content, and transglutaminase activity in cultured human ectocervical epithelial cells. Exp. Cell Res., 205, 84-90, 1993.
18. Sizemore, N., and Rorke, E. A. Human papillomavirus 16 immortalization of normal human ectocervical epithelial cells alters retinoic acid regulation of cell growth and epidermal growth factor receptor expression. Cancer Res., 53: 4511-4517, 1993.
19. Andreatta-van Leyen, S., Hembree, J. R., and Eckert, R. L. Regulation of insulin-like growth factor 1 binding protein 3 levels by epidermal growth factor and retinoic acid in cervical epithelial cells. J. Cell. Physiol., 160: 265-274, 1994
20. Choo, C. K., Rorke, E. A., and Eckert, R. L. Reunoid regulation of cell differentiation in a series of human papillomavirus type 16-immortalized human cervical epithelial cell lines. Carcinogenesis (Lond.), 16: 375-381, 1995.
21. Hembree, J. R., Agarwal, C., and Eckert, R. L Epidermal growth factor suppresses insulin-like growth factor binding protein 3 levels in human papillomavirus type 16-immortalized cervical epithelial cells and thereby potentiates the effects of insulin-like growth factor 1 Cancer Res , 54: 3160-3166, 1994.
22. LeRoith, D., McGuinness, M , Sherner, J., Stannard, B., Lanau, F., Faria, T. N., Kato, H., Werner, H . Adamo, M., and Roberts, C. T., Jr. Insulin-like growth factors. Biol. Signals, 1: 173-181, 1992.
23. Love, Jr., W L Biological actions of insulin-like growth factors In: D. LeRoith (ed.), Insulin-like Growth Factors: Molecular and Cellular Aspects, pp. 49-85 Boca Raton, FL: CRC Press, 1991.
24. Baxter, R. C , and Martin, J L. Binding proteins for the insulin-like growth factors: structure, regulation and function. Prog Growth Factor Res , 1: 49-68, 1989.
25. Rosenfeld, R. G., Lawsort, G., Pham, H., Oh, Y., Conover, C. A., DeLeon, D. D., Donovan, S M., Ocrant, I., and Giudice, L Insulin-like growth factor binding proteins. Rec. Prog. Horm. Res., 46: 99-163, 1990.
26. Cohick, W. S., and Clemmons, D. R. The insulin-like growth factors. Annu Rev. Physiol., 55: 131-153, 1993.
27. De Mellow, J. S., and Baxter, R C Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. Biochem Biophys Res. Commun., 156: 199-204, 1988.
28. Blum, W. F., Jeune, E. W., Reppin, F., Kietsmann, K., Ranke, M. B , and Bierich, J R. Insulin-like growth factor I (IGF-I)-binding protein complex is a better mitogen than free IGF-I. Endocrinology, 125: 766-772, 1989
29. Ernst, M , and Rodan, G A. Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): positive correlation with the presence of the GH-induced IGF-binding protein BP-3. Endocrinology, 127: 807-814, 1990.
30. Conover, C. A., and Powell, D R, Insulin-like growth factor (IGF)-binding protein-3 blocks IGF-I-induced receptor down-regulation and cell desensitization in cultured bovine fibroblasts. Endocrinology, 129: 710-716, 1991.
31. Gopinath, R., Walton, P. E., and Etherton, J D. An acid-stable insulin-like growth factor (IGF)-binding protein from pig serum inhibits binding of IGF-I and IGF-II to vascular endothelial cells. J Endocrinol, 120: 231-236, 1989.
32. Bicsak, T A., Shimonaka, M., Malkowski, M., and Ling. N Insulin-like growth factor-binding proteins (IGF-BP) inhibition of granulosa cell function: effect on cyclic adenosine 3′,5′-monophosphate, deoxyribonucleic acid synthesis, and comparison with the effect of an IGF-I antibody. Endocrinology, 126: 2184-2189, 1990.
33. Conover, C. A., Roak, M., Lombana, F., and Powell, D. R. Structural and biological characterization of bovine insulin-like south factor binding protein-3 Endocrinology, 127: 2795-2803, 1990
34. Oh, Y., Muller, H. L , Pham, H , and Rosenfeld, R. G Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. J. Biol Chem , 268: 26045-26048, 1993.
35. Lippman, S M., Kessler, J. F , and Meyskens, F. L., Jr. Retinoids as preventative and therapeutic anticancer agents (Part 1) Cancer Treat. Rep., 71, 391-405, 1987
36. Lippman, S. M., Kessler, J. P., and Meyskens, F. L , Jr. Retinoids as preventative and therapeutic anticancer agents (Part 2) Cancer Treat Res., 71, 493-515, 1987.
37. Lippman, S. M , Kavanagh, J. J., Paredes-Espinoza, M., Delgadillo-Mardrueno, F., Paredes-Casillas, P , Hong, W. K., Holdener, E , and Krakoff, I. H. 13-cis-Retinoic acid plus interferon α-2a: highly active systemic therapy for squamous cell carcinoma of the cervix. J. Natl Cancer Inst., 84, 241-245, 1992.
38. Nagpal, S., Athanikar, J., and Chandraratna, R. A. S. Separation of transactivation and AP1 antagonism functions of retinoic acid receptor α. J. Biol. Chem., 270: 923-927, 1995
39. Agarwal, C., Rorke, E. A., Irwin, J. C., and Eckert, R. L. Immortalization by human papillomavirus type 16 alters retinoid regulation of human ectocervical epithelial cell differentiation. Cancer Res., 51 3982-3989, 1991
40. Loeliger, P., Gollag, W., and Mayer, H. Arotinoids, a new class of highly active retinoids Eur. J. Med. Chem., 15: 9-15, 1980.
41. Agarwal, C., Chandraratna, R A. S., Teng, M., Nagpal, S., Rorke, E. A., and Eckert, R. L. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by RXR- and RAR-specific retinoids. Cell Growth & Differ., 7: 521-530, 1996.
42. Hossenlopp, P., Seurin, D., Segovia-Quinson, B., Hardouin, S., and Binoux, M Analysis of serum insulin-like growth factor binding proteins using Western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal. Biochem., 154: 138-143, 1986.
43. Lotan, R., Dawson, M. I., Zou, C-C., Jong, L , Lotan, D. and Zou, C-P. Enhanced efficacy of combinations of retinoic acid- and retinoic X receptor-selective retinoids and α-interferon in inhibition of cervical carcinoma cell proliferation. Cancer Res , 55, 232-236, 1995.
44. Baserga, R. The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res., 55: 249-252, 1995.
45. Thacher, S., Athanikar, S., Kopper, S., and Chandraratna, R. A. S. Retinoid induction of hairless mouse epidermal hyperplasia is RAR receptor selective. Proc. Soc. Invest. Dermatol., 102: 554, 1994.
46. Esgleyes-Ribot, T., Chandraratna, R. A. Lew-Kaya, D. A., Sefton, J., Duvic, M Response of psoriasis to a new topical retinoid, AGN190168 J Am. Acad. Dermatol., 30: 581-590, 1994.
47. Weinstein, G D., Green, L., Drake, L. A., Elias, P. M., Krueger, G. G , Lazarus, G. S., Lowe, N. J., Lew-Kaya, D. A , Lue, J., Sefton, J., Chandraratna, R. A New topical retinoid gel for therapy of psoriasis: dose-ranging study of AGN190168. Proc Soc Invest. Dermatol., 100: 544, 1993.
48. Smith, M. A., Parkinson, D. R., Cheson, B D., and Friedman, M A. Retinoids and cancer therapy. J. Clin Oncol., 10: 839-864, 1992.
49. Mangelsdorf, D. J. Vitamin A receptors. Nutr. Rev., 52: S32-S44, 1994.
50. Heyman, R. A., Mangelsdorf, D. J., Dyck, J. A., Stein, R. B., Eichele, G., Evans, R. M., and Thalier, C. 9-cis Retinoic acid is a high affinity ligand for the retinoid X receptor. Cell, 68: 397-406, 1992
51. Umesono, K., Murakami, K. K., Thompson, C. C., and Evans, R. M. Direct repeats as selective response elements for the thyroid hormone, retinoic acid and vitamin D3 receptors. Cell, 65, 1255-1266, 1991.
52. Mangelsdorf, D J., Umesono, K., and Evans, R. M. In: M B. Sporn, A. B. Roberts, and D S Goodman (eds.), The Retinoids, Ed. 2. pp. 319-349. New York: Raven Press, 1994
53. Lehmann, J. M., Zhang, X. K , Graupner, G., Lee, M O., Hermann, T., Hoffmann, B., and Pfahl, M Formation of retinoid X receptor homodimers leads to repression of T3 response: hormonal cross talk by ligand-induced squelching. Mol. Cell. Biol., 13: 7698-7707, 1993
54. Gendimenico, G J., Stim, T. B., Corbo, M., Janssen, B., and Mezick, J. A. A pleiotropic response is induced in F9 embryonal carcinoma cells and rhino mouse skin by all-trans-retinoic acid, a RAR agonist but not by SR11237, a RXR-selecnve agonist. J. Invest Dermatol., 702: 676-680, 1994.
55. Allegretto, E. A., McClurg, M. R , Lazarchik, S B , Clemm, D. L., Kerner, S. A., Elgort, M. G., Boehm, M. F., White, S K , Pike, J. W., and Heyman, R. A. Transactivation properties of retinoic acid and retinoid X receptors in mammalian cells and yeast. Correlation with hormone binding and effects of metabolism J. Biol. Chem , 268: 26625-26633, 1993.